The lactulose/mannitol (IJM) intestinal permeability test is a simple investigative tool currently used in the diagnostic investigation of patients with suspected coeliac disease. After an orally administered dose of sugar probes, patients with active coeliac disease usually show higher lactulose and lower mannitol urinary recovery (UR), with a pronounced increase in the LJM UR. These changes have mostly been found in selected groups of symptomatic patients. 2 In recent years it has become clear that many patients with coeliac disease escape diagnosis.3 Despite typical coeliac damage at jejunal biopsy, many patients often show only minor symptoms or are apparently healthy. Treat (1-0) (range 11-6-14-1) years. In each patient the diagnosis of coeliac disease was confirmed by intestinal biopsy according to currently accepted criteria.6 All the patients with coeliac disease in this study were either free from major symptoms or showed a low grade intensity illness. The most common clinical findings were iron deficiency, recurrent abdominal pain, and behavioural disturbances.
CONTROLS
These were 54 randomly selected age matched students participating in the coeliac screening. They were considered to be free of coeliac disease because of normal results in the IgG-AGA test, the IgA-AGA test, the AEA test, and the serum immunoglobulin measurements. In a large multicentre study the negative predictive value of this serological pattern was as high as 99/3%.7 Controls comprised 23 male and 31 female subjects with a mean age of 12-7 (SD 0 9) (range 11-3-14-0) years.
METHODS
The LJM test was performed after an overnight fast and bladder emptying. A total of 5 g lactulose and 2 g mannitol in 150 ml water was given orally (isotonic load). All urine passed in the subsequent five hours was collected, the volume recorded, and an aliquot preserved at -20°C with sodium azide. The urinary concentration of each sugar was measured by high performance liquid chromatography as previously described8 and the ratio of recovered to ingested sugar was calculated as a percentage (lactulose% UR and mannitol% UR). The ratio of the lactulose% UR to the mannitol% UR (LO/o/M%) was evaluated. The difference between the result of the haematological investigations in patients with coeliac disease with either a normal or a pathological value of the LO/o/M% urinary ratio has been analysed by a Student's t test for independent samples.
Results Figures 1 and 2 show the results of the intestinal permeability study. The median lactulose% UR was significantly higher in patients with coeliac disease than in controls (0-63 v 0-18, p<0001); the mean mannitol% UR was lower in patients with coeliac disease than in controls (1 7.6 v 1 8 5) but the difference was not significant. The median LO/o/M% UR was significantly higher in patients with coeliac disease than in controls (0-038 v 0-014, p<0 001). However, 16, 15, and 27 of the 29 patients with coeliac disease respectively showed an LO/o/M% ratio, a lactulose% UR, and a mannitol% UR within normal limits. Based on the LO/o/M% UR, regarded as the most discriminating permeability index between controls and patients with coeliac disease,9 the sensitivity of the intestinal permeability test (subjects with a positive test x 100/number of patients with coeliac disease) was 45%.
The comparison between patients with coeliac disease with a normal LO/o/M% urinary ratio and those with an LO/o/M% UR higher than the cut off level (0 044) showed no significant difference in clinical presentation, the serological coeliac disease marker pattern, the histological picture, and the routine haematological investigations. 
